Paediatric haematology,
oncology and haemostaseology
-
PD Dr. med. Dirk Schwabe
|
|
| |
> |
Expertise
- Treatment of childhood oncologic
and haematologic diseases
with a special focus on allogeneic
and autologous haematologic
stem cell transplantation.
|
|
> |
Resources
and Abilities
- Design and coordination
of phase I/II clinical trials
|
|
| |
| >
|
Publications
- Koehl U, Zimmermann S, Esser
R, Sörensen J, Grüttner
HP, Duchscherer M, Seifried
E, Klingebiel T, Schwabe D.
Autologous transplantation
of CD133 selected haematopoietic
progenitor cells in a paediatric
patient with relapsed leukemia.
Bone Marrow Transplant 2002;29:927-30.
- Zimmermann S, Klingebiel
T, Koehl U, Sörensen
J, Schwabe D. Tecelac as antithymocyte
globulin in childhood allogeneic
stem cell transplantation.
Bone Marrow Transplant 2002;29:957-62.
- Tonn T, Becker S, Esser
R, Schwabe D, Seifried E.
Cellular Immunotherapy of
malignancies using the clonal
natural killer cell line NK-92.
J Hematother Stem Cell Res
2001;10:535-44.
|
|
| |
> |
Staff:
- Jan Sörensen
- Dr Hans-Peter Grüttner
|
| >
|
ZAFES-Coordinator:
|
|
|
